HEADER HYDROLASE 14-FEB-06 2G1N TITLE KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THE "C" RING COMPND MOL_ID: 1; COMPND 2 MOLECULE: RENIN; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ANGIOTENSINOGENASE; COMPND 5 EC: 3.4.23.15; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: REN; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROTEIN-LIGAND COMPLEXES, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR D.D.HOLSWORTH REVDAT 4 29-JUL-20 2G1N 1 COMPND REMARK HETNAM LINK REVDAT 4 2 1 SITE REVDAT 3 13-JUL-11 2G1N 1 VERSN REVDAT 2 24-FEB-09 2G1N 1 VERSN REVDAT 1 13-JUN-06 2G1N 0 JRNL AUTH D.D.HOLSWORTH,C.CAI,X.M.CHENG,W.L.CODY,D.M.DOWNING,N.ERASGA, JRNL AUTH 2 C.LEE,N.A.POWELL,J.J.EDNUNDS,M.STIER,M.JALAIE,E.ZHANG, JRNL AUTH 3 P.MCCONNELL,M.J.RYAN,J.BRYANT,T.LI,A.KASANI,E.HALL,R.SUBEDI, JRNL AUTH 4 M.RAHIM,S.MAITI JRNL TITL KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THE JRNL TITL 2 "C" RING JRNL REF BIOORG.MED.CHEM.LETT. V. 16 2500 2006 JRNL REFN ISSN 0960-894X JRNL PMID 16480874 JRNL DOI 10.1016/J.BMCL.2006.01.084 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 20323 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.285 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2000 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5144 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 86 REMARK 3 SOLVENT ATOMS : 353 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2G1N COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-FEB-06. REMARK 100 THE DEPOSITION ID IS D_1000036575. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20323 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 1.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : 1.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.22 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.26 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 3 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 5555 Z,X,Y REMARK 290 6555 Z+1/2,-X+1/2,-Y REMARK 290 7555 -Z+1/2,-X,Y+1/2 REMARK 290 8555 -Z,X+1/2,-Y+1/2 REMARK 290 9555 Y,Z,X REMARK 290 10555 -Y,Z+1/2,-X+1/2 REMARK 290 11555 Y+1/2,-Z+1/2,-X REMARK 290 12555 -Y+1/2,-Z,X+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 71.01350 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 71.01350 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 71.01350 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 71.01350 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 71.01350 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 71.01350 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY2 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY1 6 0.000000 0.000000 1.000000 71.01350 REMARK 290 SMTRY2 6 -1.000000 0.000000 0.000000 71.01350 REMARK 290 SMTRY3 6 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY1 7 0.000000 0.000000 -1.000000 71.01350 REMARK 290 SMTRY2 7 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 1.000000 0.000000 71.01350 REMARK 290 SMTRY1 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY2 8 1.000000 0.000000 0.000000 71.01350 REMARK 290 SMTRY3 8 0.000000 -1.000000 0.000000 71.01350 REMARK 290 SMTRY1 9 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 9 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY3 9 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY1 10 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 10 0.000000 0.000000 1.000000 71.01350 REMARK 290 SMTRY3 10 -1.000000 0.000000 0.000000 71.01350 REMARK 290 SMTRY1 11 0.000000 1.000000 0.000000 71.01350 REMARK 290 SMTRY2 11 0.000000 0.000000 -1.000000 71.01350 REMARK 290 SMTRY3 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY1 12 0.000000 -1.000000 0.000000 71.01350 REMARK 290 SMTRY2 12 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY3 12 1.000000 0.000000 0.000000 71.01350 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 70 -53.89 -139.17 REMARK 500 ALA A 111 -72.43 -49.10 REMARK 500 ASP A 120 -65.65 -98.81 REMARK 500 ASP A 160 89.33 -43.02 REMARK 500 SER A 164 82.76 -58.04 REMARK 500 GLN A 165 -28.52 -164.56 REMARK 500 LYS A 192 147.94 170.45 REMARK 500 LYS A 201 53.89 -102.88 REMARK 500 SER A 208 96.31 174.58 REMARK 500 LEU A 210 36.51 -82.58 REMARK 500 ASP A 214 10.00 57.85 REMARK 500 TYR A 226 -169.18 -116.86 REMARK 500 ARG A 246 -152.29 -118.81 REMARK 500 ASP A 249 -171.32 -174.24 REMARK 500 LYS A 253 113.36 -31.65 REMARK 500 CYS A 254 -38.60 -36.37 REMARK 500 LYS A 270 121.61 178.77 REMARK 500 ALA A 294 42.40 -77.75 REMARK 500 ASP A 299 73.63 -103.99 REMARK 500 ASN A 327 63.45 37.98 REMARK 500 ASP B 12 18.65 56.97 REMARK 500 SER B 47 141.02 -23.98 REMARK 500 THR B 51 -2.19 -56.89 REMARK 500 CYS B 53 14.82 -69.44 REMARK 500 SER B 62 5.85 -69.44 REMARK 500 THR B 82 116.64 -179.31 REMARK 500 VAL B 94 59.84 -96.52 REMARK 500 THR B 100 109.94 -48.34 REMARK 500 ASP B 120 -65.26 -104.18 REMARK 500 GLN B 145 6.11 -68.74 REMARK 500 SER B 164 139.13 167.45 REMARK 500 GLN B 165 62.41 -106.35 REMARK 500 LYS B 192 -154.97 -146.91 REMARK 500 SER B 207 33.86 -170.93 REMARK 500 CYS B 216 -153.19 -161.43 REMARK 500 ARG B 246 -94.64 -77.52 REMARK 500 PHE B 248 -64.61 -129.08 REMARK 500 PRO B 258 -18.56 -48.28 REMARK 500 SER B 276 -44.77 -28.40 REMARK 500 ALA B 294 38.65 -93.09 REMARK 500 MET B 298 78.82 -158.72 REMARK 500 ASN B 327 56.54 33.36 REMARK 500 ALA B 332 140.15 -175.69 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2G1O RELATED DB: PDB REMARK 900 RELATED ID: 2G1R RELATED DB: PDB REMARK 900 RELATED ID: 2G1S RELATED DB: PDB REMARK 900 RELATED ID: 2G1Y RELATED DB: PDB REMARK 900 RELATED ID: 2G20 RELATED DB: PDB REMARK 900 RELATED ID: 2G21 RELATED DB: PDB REMARK 900 RELATED ID: 2G22 RELATED DB: PDB REMARK 900 RELATED ID: 2G24 RELATED DB: PDB REMARK 900 RELATED ID: 2G26 RELATED DB: PDB REMARK 900 RELATED ID: 2G27 RELATED DB: PDB DBREF 2G1N A 3 335 UNP P00797 RENI_HUMAN 74 406 DBREF 2G1N B 3 335 UNP P00797 RENI_HUMAN 74 406 SEQRES 1 A 333 SER SER VAL ILE LEU THR ASN TYR MET ASP THR GLN TYR SEQRES 2 A 333 TYR GLY GLU ILE GLY ILE GLY THR PRO PRO GLN THR PHE SEQRES 3 A 333 LYS VAL VAL PHE ASP THR GLY SER SER ASN VAL TRP VAL SEQRES 4 A 333 PRO SER SER LYS CYS SER ARG LEU TYR THR ALA CYS VAL SEQRES 5 A 333 TYR HIS LYS LEU PHE ASP ALA SER ASP SER SER SER TYR SEQRES 6 A 333 LYS HIS ASN GLY THR GLU LEU THR LEU ARG TYR SER THR SEQRES 7 A 333 GLY THR VAL SER GLY PHE LEU SER GLN ASP ILE ILE THR SEQRES 8 A 333 VAL GLY GLY ILE THR VAL THR GLN MET PHE GLY GLU VAL SEQRES 9 A 333 THR GLU MET PRO ALA LEU PRO PHE MET LEU ALA GLU PHE SEQRES 10 A 333 ASP GLY VAL VAL GLY MET GLY PHE ILE GLU GLN ALA ILE SEQRES 11 A 333 GLY ARG VAL THR PRO ILE PHE ASP ASN ILE ILE SER GLN SEQRES 12 A 333 GLY VAL LEU LYS GLU ASP VAL PHE SER PHE TYR TYR ASN SEQRES 13 A 333 ARG ASP SER GLU ASN SER GLN SER LEU GLY GLY GLN ILE SEQRES 14 A 333 VAL LEU GLY GLY SER ASP PRO GLN HIS TYR GLU GLY ASN SEQRES 15 A 333 PHE HIS TYR ILE ASN LEU ILE LYS THR GLY VAL TRP GLN SEQRES 16 A 333 ILE GLN MET LYS GLY VAL SER VAL GLY SER SER THR LEU SEQRES 17 A 333 LEU CYS GLU ASP GLY CYS LEU ALA LEU VAL ASP THR GLY SEQRES 18 A 333 ALA SER TYR ILE SER GLY SER THR SER SER ILE GLU LYS SEQRES 19 A 333 LEU MET GLU ALA LEU GLY ALA LYS LYS ARG LEU PHE ASP SEQRES 20 A 333 TYR VAL VAL LYS CYS ASN GLU GLY PRO THR LEU PRO ASP SEQRES 21 A 333 ILE SER PHE HIS LEU GLY GLY LYS GLU TYR THR LEU THR SEQRES 22 A 333 SER ALA ASP TYR VAL PHE GLN GLU SER TYR SER SER LYS SEQRES 23 A 333 LYS LEU CYS THR LEU ALA ILE HIS ALA MET ASP ILE PRO SEQRES 24 A 333 PRO PRO THR GLY PRO THR TRP ALA LEU GLY ALA THR PHE SEQRES 25 A 333 ILE ARG LYS PHE TYR THR GLU PHE ASP ARG ARG ASN ASN SEQRES 26 A 333 ARG ILE GLY PHE ALA LEU ALA ARG SEQRES 1 B 333 SER SER VAL ILE LEU THR ASN TYR MET ASP THR GLN TYR SEQRES 2 B 333 TYR GLY GLU ILE GLY ILE GLY THR PRO PRO GLN THR PHE SEQRES 3 B 333 LYS VAL VAL PHE ASP THR GLY SER SER ASN VAL TRP VAL SEQRES 4 B 333 PRO SER SER LYS CYS SER ARG LEU TYR THR ALA CYS VAL SEQRES 5 B 333 TYR HIS LYS LEU PHE ASP ALA SER ASP SER SER SER TYR SEQRES 6 B 333 LYS HIS ASN GLY THR GLU LEU THR LEU ARG TYR SER THR SEQRES 7 B 333 GLY THR VAL SER GLY PHE LEU SER GLN ASP ILE ILE THR SEQRES 8 B 333 VAL GLY GLY ILE THR VAL THR GLN MET PHE GLY GLU VAL SEQRES 9 B 333 THR GLU MET PRO ALA LEU PRO PHE MET LEU ALA GLU PHE SEQRES 10 B 333 ASP GLY VAL VAL GLY MET GLY PHE ILE GLU GLN ALA ILE SEQRES 11 B 333 GLY ARG VAL THR PRO ILE PHE ASP ASN ILE ILE SER GLN SEQRES 12 B 333 GLY VAL LEU LYS GLU ASP VAL PHE SER PHE TYR TYR ASN SEQRES 13 B 333 ARG ASP SER GLU ASN SER GLN SER LEU GLY GLY GLN ILE SEQRES 14 B 333 VAL LEU GLY GLY SER ASP PRO GLN HIS TYR GLU GLY ASN SEQRES 15 B 333 PHE HIS TYR ILE ASN LEU ILE LYS THR GLY VAL TRP GLN SEQRES 16 B 333 ILE GLN MET LYS GLY VAL SER VAL GLY SER SER THR LEU SEQRES 17 B 333 LEU CYS GLU ASP GLY CYS LEU ALA LEU VAL ASP THR GLY SEQRES 18 B 333 ALA SER TYR ILE SER GLY SER THR SER SER ILE GLU LYS SEQRES 19 B 333 LEU MET GLU ALA LEU GLY ALA LYS LYS ARG LEU PHE ASP SEQRES 20 B 333 TYR VAL VAL LYS CYS ASN GLU GLY PRO THR LEU PRO ASP SEQRES 21 B 333 ILE SER PHE HIS LEU GLY GLY LYS GLU TYR THR LEU THR SEQRES 22 B 333 SER ALA ASP TYR VAL PHE GLN GLU SER TYR SER SER LYS SEQRES 23 B 333 LYS LEU CYS THR LEU ALA ILE HIS ALA MET ASP ILE PRO SEQRES 24 B 333 PRO PRO THR GLY PRO THR TRP ALA LEU GLY ALA THR PHE SEQRES 25 B 333 ILE ARG LYS PHE TYR THR GLU PHE ASP ARG ARG ASN ASN SEQRES 26 B 333 ARG ILE GLY PHE ALA LEU ALA ARG MODRES 2G1N ASN A 70 ASN GLYCOSYLATION SITE MODRES 2G1N ASN B 70 ASN GLYCOSYLATION SITE HET NAG A 985 14 HET 1IG A 885 29 HET NAG B 986 14 HET 1IG B 886 29 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM 1IG N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2- HETNAM 2 1IG DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4- HETNAM 3 1IG YL]ETHYL}ACETAMIDE FORMUL 3 NAG 2(C8 H15 N O6) FORMUL 4 1IG 2(C20 H26 N6 O2 S) FORMUL 7 HOH *353(H2 O) HELIX 1 1 TYR A 50 TYR A 55 1 6 HELIX 2 2 PRO A 110 MET A 115 1 6 HELIX 3 3 PHE A 127 VAL A 135 5 9 HELIX 4 4 PRO A 137 SER A 144 1 8 HELIX 5 5 ASP A 177 GLN A 179 5 3 HELIX 6 6 SER A 230 ALA A 240 1 11 HELIX 7 7 ASN A 255 GLY A 257 5 3 HELIX 8 8 THR A 275 VAL A 280 1 6 HELIX 9 9 GLY A 311 ARG A 316 1 6 HELIX 10 10 ASP B 60 SER B 64 5 5 HELIX 11 11 PRO B 110 MET B 115 1 6 HELIX 12 12 PHE B 127 VAL B 135 5 9 HELIX 13 13 PRO B 137 GLN B 145 1 9 HELIX 14 14 ASP B 177 TYR B 181 5 5 HELIX 15 15 SER B 230 ALA B 240 1 11 HELIX 16 16 ASN B 255 LEU B 260 5 6 HELIX 17 17 THR B 275 TYR B 279 1 5 HELIX 18 18 GLY B 311 LYS B 317 1 7 SHEET 1 A 6 SER A 4 TYR A 10 0 SHEET 2 A 6 GLN A 14 ILE A 21 -1 O TYR A 16 N THR A 8 SHEET 3 A 6 GLN A 26 ASP A 33 -1 O GLN A 26 N ILE A 21 SHEET 4 A 6 GLY A 121 GLY A 124 1 O VAL A 123 N VAL A 31 SHEET 5 A 6 VAL A 39 PRO A 42 -1 N TRP A 40 O VAL A 122 SHEET 6 A 6 ILE A 97 GLU A 108 1 O GLY A 104 N VAL A 39 SHEET 1 B 7 THR A 82 VAL A 94 0 SHEET 2 B 7 LYS A 68 ARG A 77 -1 N THR A 72 O LEU A 87 SHEET 3 B 7 THR A 82 VAL A 94 -1 O LEU A 87 N THR A 72 SHEET 4 B 7 GLN A 14 ILE A 21 -1 N GLY A 20 O THR A 93 SHEET 5 B 7 SER A 4 TYR A 10 -1 N THR A 8 O TYR A 16 SHEET 6 B 7 GLY A 169 LEU A 173 -1 O GLY A 169 N LEU A 7 SHEET 7 B 7 VAL A 152 TYR A 157 -1 N SER A 154 O VAL A 172 SHEET 1 C 8 PHE A 318 ASP A 323 0 SHEET 2 C 8 ARG A 328 ALA A 334 -1 O GLY A 330 N GLU A 321 SHEET 3 C 8 ILE A 188 ASN A 189 -1 N ILE A 188 O ILE A 329 SHEET 4 C 8 ARG A 328 ALA A 334 -1 O ILE A 329 N ILE A 188 SHEET 5 C 8 TYR A 181 GLU A 182 -1 N GLU A 182 O LEU A 333 SHEET 6 C 8 ARG A 328 ALA A 334 -1 O LEU A 333 N GLU A 182 SHEET 7 C 8 VAL A 152 TYR A 157 0 SHEET 8 C 8 GLY A 169 LEU A 173 -1 O VAL A 172 N SER A 154 SHEET 1 D 7 GLU A 271 LEU A 274 0 SHEET 2 D 7 ILE A 263 LEU A 267 -1 N PHE A 265 O TYR A 272 SHEET 3 D 7 GLN A 197 SER A 204 -1 N SER A 204 O SER A 264 SHEET 4 D 7 CYS A 216 VAL A 220 -1 O ALA A 218 N ILE A 198 SHEET 5 D 7 TRP A 308 LEU A 310 1 O TRP A 308 N LEU A 219 SHEET 6 D 7 ILE A 227 GLY A 229 -1 N SER A 228 O ALA A 309 SHEET 7 D 7 ILE A 295 ALA A 297 1 O HIS A 296 N ILE A 227 SHEET 1 E 3 LYS A 244 LYS A 245 0 SHEET 2 E 3 TYR A 250 LYS A 253 -1 O VAL A 251 N LYS A 244 SHEET 3 E 3 LEU A 290 THR A 292 -1 O CYS A 291 N VAL A 252 SHEET 1 F 4 GLN B 26 VAL B 30 0 SHEET 2 F 4 GLN B 14 ILE B 21 -1 N GLY B 17 O VAL B 30 SHEET 3 F 4 THR B 82 THR B 93 -1 O THR B 93 N GLY B 20 SHEET 4 F 4 GLU B 73 ARG B 77 -1 N LEU B 76 O VAL B 83 SHEET 1 G12 PHE B 32 ASP B 33 0 SHEET 2 G12 VAL B 122 GLY B 124 1 N VAL B 123 O ASP B 33 SHEET 3 G12 VAL B 39 PRO B 42 -1 N TRP B 40 O VAL B 122 SHEET 4 G12 THR B 98 GLU B 108 1 O VAL B 106 N VAL B 41 SHEET 5 G12 THR B 82 THR B 93 -1 N SER B 88 O PHE B 103 SHEET 6 G12 GLN B 14 ILE B 21 -1 N GLY B 20 O THR B 93 SHEET 7 G12 SER B 4 TYR B 10 -1 N THR B 8 O TYR B 16 SHEET 8 G12 GLY B 169 LEU B 173 -1 O GLY B 169 N LEU B 7 SHEET 9 G12 VAL B 152 TYR B 157 -1 N TYR B 156 O GLN B 170 SHEET 10 G12 PHE B 318 ASP B 323 -1 O THR B 320 N PHE B 155 SHEET 11 G12 ARG B 328 LEU B 333 -1 O ALA B 332 N TYR B 319 SHEET 12 G12 HIS B 186 ASN B 189 -1 N ILE B 188 O ILE B 329 SHEET 1 H 3 GLN B 197 MET B 200 0 SHEET 2 H 3 CYS B 216 VAL B 220 -1 O ALA B 218 N ILE B 198 SHEET 3 H 3 TRP B 308 LEU B 310 1 O TRP B 308 N LEU B 219 SHEET 1 I 3 GLY B 202 VAL B 205 0 SHEET 2 I 3 ILE B 263 LEU B 267 -1 O SER B 264 N SER B 204 SHEET 3 I 3 LYS B 270 LEU B 274 -1 O TYR B 272 N PHE B 265 SHEET 1 J 2 ILE B 227 GLY B 229 0 SHEET 2 J 2 ILE B 295 ALA B 297 1 O HIS B 296 N ILE B 227 SHEET 1 K 4 LYS B 244 LYS B 245 0 SHEET 2 K 4 TYR B 250 LYS B 253 -1 O VAL B 251 N LYS B 244 SHEET 3 K 4 LEU B 290 LEU B 293 -1 O CYS B 291 N VAL B 252 SHEET 4 K 4 VAL B 280 PHE B 281 -1 N PHE B 281 O THR B 292 SSBOND 1 CYS A 46 CYS A 53 1555 1555 2.03 SSBOND 2 CYS A 212 CYS A 216 1555 1555 2.04 SSBOND 3 CYS A 254 CYS A 291 1555 1555 2.04 SSBOND 4 CYS B 46 CYS B 53 1555 1555 2.02 SSBOND 5 CYS B 212 CYS B 216 1555 1555 2.03 SSBOND 6 CYS B 254 CYS B 291 1555 1555 2.04 LINK ND2 ASN A 70 C1 NAG A 985 1555 1555 1.45 LINK ND2 ASN B 70 C1 NAG B 986 1555 1555 1.45 CISPEP 1 THR A 23 PRO A 24 0 0.06 CISPEP 2 LEU A 112 PRO A 113 0 0.20 CISPEP 3 PRO A 302 PRO A 303 0 0.22 CISPEP 4 GLY A 305 PRO A 306 0 -0.03 CISPEP 5 THR B 23 PRO B 24 0 0.14 CISPEP 6 LEU B 112 PRO B 113 0 -0.12 CISPEP 7 PRO B 302 PRO B 303 0 -0.09 CISPEP 8 GLY B 305 PRO B 306 0 0.09 CRYST1 142.027 142.027 142.027 90.00 90.00 90.00 P 21 3 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007041 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007041 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007041 0.00000